Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Opioid-sparing Effect of Intravenous Ibuprofen

NCT03016650 is registered in ClinicalTrials.gov with Muharrem Ucar as lead sponsor.

NCT NCT03016650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03016650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Opioid-sparing Effect of Intravenous Ibuprofen
Lead sponsor
Muharrem Ucar
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2017
Completion date
May 31, 2017
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, percutaneous nephrolithotomy